Robert F. Williamson III, Director at Perspective Therapeutics, Inc. (CATX), bought 6,266 shares at $3.62 ($23K) on 2024-11-25, disclosed to the SEC on 2024-11-27.
Open-market purchase of $23k CATX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.62 | 3,647 | $13K | 57.9% |
| 2 | $3.67 | 2,619 | $10K | 42.1% |
| Total | $3.64 avg | 6,266 | $23K | 100% |
| Filing → |
| CATX | BUY | 2024-06-03 | $76K | — | Filing → |
| CATX | BUY | 2024-05-30 | $40K | — | Filing → |
| CATX | BUY | 2024-02-01 | $91K | — | Filing → |